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Background: A growing number of non-coding regulatory mutations are being identified in congenital disease.
Very recently also some exons of protein coding genes have been identified to act as tissue specific enhancer
elements and were therefore termed exonic enhancers or “eExons”.
Methods: We screened a cohort of 134 unrelated families with split-hand/split-foot malformation (SHFM) with high
resolution array CGH for CNVs with regulatory potential.
Results: In three families with an autosomal dominant non-syndromic SHFM phenotype we detected microdeletions
encompassing the exonic enhancer (eExons) 15 and 17 of DYNC1I1. In a fourth family, who had hearing loss in
addition to SHFM, we found a larger deletion of 510 kb including the eExons of DYNC1I1 and, in addition, the human
brain enhancer hs1642. Exons 15 and 17 of DYNC1I1 are known to act as tissue specific limb enhancers of DLX5/6,
two genes that have been shown to be associated with SHFM in mice. In our cohort of 134 unrelated families with
SHFM, deletions of the eExons of DYNC1I1 account for approximately 3% of the cases, while 17p13.3 duplications
were identified in 13% of the families, 10q24 duplications in 12%, and TP63 mutations were detected in 4%.
Conclusions: We reduce the minimal critical region for SHFM1 to 78 kb. Hearing loss, however, appears to be
associated with deletions of a more telomeric region encompassing the brain enhancer element hs1642. Thus,
SHFM1 as well as hearing loss at the same locus are caused by deletion of regulatory elements. Deletions of the
exons with regulatory potential of DYNC1I1 are an example of the emerging role of exonic enhancer elements and
their implications in congenital malformation syndromes.
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Split-hand/split-foot malformation (SHFM; OMIM
183600), also referred to as ectrodactyly, is a congenital
limb malformation, characterized by a claw-like appear-
ance of the distal portion of the upper and lower limbs
with profound median clefts of hands and feet and
missing or malformed central fingers [1]. This disorder
is clinically heterogeneous, comprising both isolated as
well as syndromic forms [2]. SHFM is typically inherited
as an autosomal dominant trait with incomplete pene-
trance, variable expressivity and segregation distortion
[3]. However, autosomal recessive inheritance has been
reported [4-6]. The pathogenesis of SHFM has been
studied in various mouse models. A failure to maintain
signalling from the median apical ectodermal ridge
(AER) has been shown to be a main pathogenic mechan-
ism [7-9]. Without this signalling, cells of the underlying
progress zone stop proliferation and differentiation
which in turn results in defects of the central rays. The
time point and extent of this signalling deficit deter-
mines the phenotype. Early and more extensive defects
will result in more severe deficiencies and vice versa.
At least 5 different loci have been associated with non-
syndromic SHFM. The most common form, which
may also feature long bone (tibial hemimelia) deficiency
(SHFLD) is caused by duplications involving the gene
BHLHA9 [10] (SHFLD3; MIM 612576). SHFM3 (OMIM
600095) is associated with the duplication of chromo-
some 10q24-q25, which encompasses the Dactylin gene
(FBXW4) [11]. SHFM4 (OMIM 605289) is caused
by mutations in TP63 on 3q27 [12]. The gene appears
to be essential for ectodermal development and a
deficiency affects function and maintenance of the
AER. SHFM5 (OMIM 606708) maps to 2q31. Although
the disease gene has not been identified for this locus
yet, a contribution of HOXD gene cluster has been sug-
gested for SHFM5 [13]. SHFM1 (OMIM 183600) maps
to 7q21.2-q21.3 including the genes DLX5, DLX6 and
SHFM1.
SHFM1 is an autosomal dominant trait with reduced
penetrance and variable expression ranging from mild
defects of a single limb to severe abnormalities of all
four extremities [14]. SHFM1 is associated with mental
retardation in 33% of patients, craniofacial malforma-
tions in more than 35% of patients, and deafness in 35%
of patients (SHFM1D; OMIM 220600) [15]. Physical
mapping of the SHFM1 locus on chromosome 7 defined
a critical interval of about 1.5 Mb that encompasses
SHFM1 (deleted in the split-hand/split-foot 1 region),
Dlx5 and Dlx6 (distal less-related homeobox gene 5 and
6), of which only Dlx5/6 have been shown to play a role
in early limb development [16,17]. The Dlx5 and Dlx6
are expressed in the AER of the embryonic limb buds,
craniofacial prominence, otic vesicle, and in the brain.Dlx5 deficient mice do not show any limb defects [18].
However, disruption of both Dlx5 and Dlx6 in mice
leads to ectrodactyly [7]. So far a single consanguineous
family with severe SHFM1 phenotype and hearing
impairment was demonstrated to carry a homozygous
missense mutation in DLX5 [19]. Furthermore, Wang
et al. identified a novel heterozygous missense mutation
in exon 3 of DLX5 in a Chinese family with autosomal
dominant SHFM1 [20].
Recently, exons 15 and 17 of DYNC1I1 (dynein cyto-
plasmic 1 intermediate chain 1) were identified as “cod-
ing” limb enhancers of Dlx5/6 in mice and zebrafish
[21]. The two coding exons act as “exonic enhancers”
or “eExons” and were shown to physically interact with
the promoters of Dlx5/6 in mice using chromosome
conformation capture analysis [21]. Dync1i1 itself is not
expressed during limb development. In addition, an en-
hancer element within the intronic region of SLC25A13
(solute carrier family 25 member 13) was shown to regu-
late tissue specific Dlx5/6 expression in the otic vesicle,
forebrain, branchial arch and limb bud mesenchyme.
The deletion of Slc25a13 in mice is not associated with
a SHFM phenotype [22-24].
Here we report on three unrelated families with over-
lapping deletions of the cis-regulatory eExons 15 and 17
of DYNC1I1 located over 900 kb centromeric to their
target genes DLX5/6 on chromosome 7q21.3. In a fourth
family presenting with SHFM and hearing loss we de-
tected a 510 kb deletion including the eExons 15 and 17
of DYNC1I1 but also SLC25A13, C7orf76, and several
brain enhancers. In our cohort of 134 unrelated families
with SHFM and SHFLD deletions of the eExons of
DYNC1I1 on chromosome 7q21.3 account for approxi-
mately 3% of the cases. These data have a direct impact
on SHFM1 diagnostics and further highlight the role of
regulatory mutations and structural variations in con-
genital disease.Material and methods
Patients
In a cohort of 134 unrelated families with SHFM we
excluded the known causes of SHFM and SHFLD i.e.
17p13.3 duplications with ectrodactyly and tibia hemimelia
[25], 10q24 duplications and mutations in TP63 with the
clinical manifestation of ectrodactyly without tibial involve-
ment by quantitative real-time PCR (qPCR) and Sanger se-
quencing, respectively [25]. Balanced rearrangements were
not excluded. The remaining families were used to screen
for CNVs using high resolution (1 M Agilent) array CGH.
Written informed consent was obtained from all individuals
studied, or their parents or guardians in the case of children
under 16, to participate in the study and for publication
of this manuscript and any accompanying images. The
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Berlin ethics committee as well as by the Institutional
Review Board of Poznan University of Medical Sciences.Microarray-based comparative genomic hybridization
(array CGH)
All experiments were done with genomic DNA extracted
from blood samples. Array CGH for family 1, 3, and 4 was
carried out using a whole genome 1 M oligonucleotide array
(Agilent, Santa Clara, CA). 1 M arrays were analyzed by
Feature Extraction v9.5.3.1 and CGH Analytics v3.4.40 soft-
ware or Cytogenomics v2.5.8.11, respectively (Agilent, Santa
Clara, CA). Family 2 was tested on Roche NimbleGen plat-
form with use of 1.4 M oligo arrays according to standard
protocols provided by the manufacturer. Analysis settings:
aberration algorithm: ADM-2; threshold: 6.0; window size:
0.2 Mb; filter: 5probes, log2ratio = 0.29. The genomic profile
was visualized by the SignalMap software (SignalMap
v1.9.0.03, NimbleGen Systems Inc.). Data were submitted
to the DECIPHER database (http://decipher.sanger.ac.uk);
accession numbers: BER284939, BER284938, BER284937,
and BER285016.Figure 1 Limb phenotypes and pedigrees of families 1 and 2. Family 1
individuals. All affected individuals showed split hands and feet in all four e
No long bone involvement or other bone phenotype was reported. There
motor development was normal. Family 2 is a non-consanguineous Germa
SHFM in both hands and feet and severe hearing loss. The hands (e) and f
other bone phenotype was reported. Neurological and motor developmenQuantitative real-time PCR (qPCR)
qPCR was performed as described previously [26,27]
using genomic DNA of the index patients and further
family members to confirm the deletions and to show
segregation with the phenotype. Primer sequences are
given in Additional file 1: Table S1.
Breakpoint analysis
The exact determination of the deletion size was done by
breakpoint spanning PCR following the qPCR analyses
and sequencing of the junction fragment (primer se-
quences and positions in Additional file 1: Table S1 and
Additional file 1: Figure S1).
PCR was performed in a total volume of 20 μl with
40 ng genomic DNA as template, 2 μl 10× PCR buffer,
0.6 μl dNTP mix (10 mM), 0.5 μl primer (10 pMol/μl),
0.6 μl MgCl2 (50 mM), 0.2 μl Taq polymerase (Rapido-
zym, Germany). PCR conditions are available upon re-
quest. The PCR products were purified by enzymatic
treatment (Exonuclease I, NEB; Shrimp Alkaline Phos-
phatase, Roche Diagnostics). For the sequencing of the
PCR products the BigDye v3.1 (Applied Biosystems) se-
quencing kit was used. PCR products were analyzed byis a non-consanguineous family from Poland with three affected
xtremities. Hands (a-d) and feet (f-i) of the affected one-year-old son.
was no history of hearing impairment in the family. Neurological and
n family with five affected individuals. All affected individuals showed
eet (j) of a 69-year-old affected female. No long bone involvement or
t was normal in all family members.
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sequencing results were processed by DNA-STAR soft-
ware (DNA-Star).
Results
Phenotypic analysis
We investigated a total of 16 affected from 4 unrelated
families.
Family 1 is a non-consanguineous family from Poland
with three affected individuals (grandfather, father and
son), all showing the classical SHFM phenotype in all
four extremities. Figure 1 (a-d & f-i) shows the hand and
feet of the affected one-year-old son. Neither long bone
involvement nor craniofacial abnormalities were noted.
There was no history of hearing impairment in the fam-
ily. Neurological and motor development was normal.
Family 2 is a non-consanguineous German family with
five affected individuals (a grandfather, two affected sistersFigure 2 Limb phenotypes and pedigree of family 3. Family 3 is a non
(grandmother, two affected sisters and their brother, and two male offsprin
all for limbs with no long bone involvement. Hearing loss was not reported
and feet (b). The father of the proband shows central ray deficiency of the
phenotype on the left hand (e) and feet (f).and their two daughters). Four affected individuals showed
SHFM in both hands and feet and, in addition, severe
hearing loss. One female showed SHFM in both hands
but only one foot and hearing loss. Figure 1 (e and j)
shows the hands and feet of a 69-year-old affected female.
Neither long bone involvement nor craniofacial abnormal-
ities were noted. Neurological and motor development
was normal in all family members.
Family 3 is a non-consanguineous family of Polish
origin with six individuals from three generations all
affected by SHFM. All patients presented with variable
limb malformations, ranging from a severe cleft in all
limbs (see index in Figure 2a, b) to milder defects, such
as absent or hypoplastic central digit (aunt of the index
in Figure 2c). None of the patients from family 3 mani-
fested long bone deficiency or hypoplasia. Psychomotor
development and hearing of all affected family members
was normal.-consanguineous family from Poland with six affected individuals
g of the brother and one of the sisters). All patients showed SHFM in
in this family. The proband shows bilateral SHFM of the hands (a)
hands (c) and right foot (d). The aunt of the proband presents milder
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affected sisters (monozygotic twins) showing a SHFM
phenotype in the hands only. Neither long bone involve-
ment nor craniofacial abnormalities were noted. There
was no history of hearing impairment in the family.
Neurological and motor development was normal.
In our cohort of patients with deletions of the eExons
of DYNC1I1 the penetrance was high. However, due to
the small sample size future studies are needed to deter-
mine the penetrance of DYNC1I1 deletions.
Deletions of the eExons 15 and 17 of DYNC1I1 are
associated with SHFM1
We identified three unrelated families with overlapping
deletions of the cis-regulatory eExons of DYNC1I1 over
900 kb centromeric to DLX5/6 with a split-hand/split
foot phenotype (Figure 3). In families 1, 3, and 4 we
detected overlapping microdeletions of 167 kb, 205 kb
and 167 kb, respectively. The deletions encompass the
eExons 15 and 17 of DYNC1I1 as well as the last three
exons of SLC25A13 including the enhancer elements
eDlx#23 within its intronic region (Figure 3). The latterFigure 3 Schematic representation of the microdeletions on 7q21.3 a
autosomal dominant non-syndromic SHFM phenotype overlapping microd
17 of DYNC1I1 (red) as well as the last three exons of SLC25A13 including th
expression in otic vesicle. The DYNC1I1 exons 15 and 17 have previously be
zebrafish [21]. In family 2 presenting with SHFM and hearing loss a 510 kb
SLC25A13, C7orf76, the brain enhancer element hs1642 and two branchial a
responsible for hearing loss in family 2. The SHFM family reported by Kouw
indicated the qPCR amplicons used in this study. Breakpoint sequences arehas been shown to drive expression in the otic vesicle,
forebrain, branchial arch and limb bud mesenchyme.
The DYNC1I1 exons 15 and 17 have previously been
shown to act as tissue-specific enhancers of Dlx5/6 in
mouse and zebrafish [21]. The deletions are therefore
likely to result in tissue-specific loss of function of
DLX5/6 in the developing hand or foot causing SHFM.
In family 2 presenting with SHFM and hearing loss we
detected a 510 kb deletion encompassing the eExons of
DYNC1I1 but also SLC25A13, C7orf76 and the human
brain enhancer element hs1642 (Figure 3).
The array CGH results were confirmed by qPCR
in the index patients. Analysis of further affected and
unaffected family members of all 4 families showed that
the microdeletions segregate with the phenotype, i.e.
unaffected family members had a normal copy number
of the region. The qPCR data showed only one copy of
the analyzed amplicons, i.e. a deletion, in all affected
individuals. Similar deletions were not observed in 200
control DNA samples and are were not present in the
Database of Genomic Variants (DGV) (http://dgv.tcag.
ca/dgv/app/home).ssociated with SHFM. In three families (Family 1, 3 and 4) with an
eletions were detected. The deletions encompass the eExons 15 and
e enhancer elements eDlx#23 (blue) within its intronic region driving
en shown to act as tissue-specific enhancers of Dlx5/6 in mouse and
deletion was identified including the eExons of DYNC1I1 but also
rch enhancers (green) [28]. The deletion of hs1642 might be
enhoven et al. developed hearing loss during adolescents [29]. P1- P4
shown in Additional file 1: Figure S1.
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In order to determine the exact breakpoints of the
microdeletions and to exclude translocations or inver-
sions, junction fragments that included the telomeric
and centromeric breakpoints were PCR amplified
and subsequently sequenced in all affected individuals.
Deletion breakpoints were detectable only in the
affected, but not in the unaffected individuals. In family
1 we detected a 167 kb deletion on 7q21.3 (genomic posi-
tion chr7:95,615,187-95,783,313). In family 2 we detected a
510 kb deletion on 7q21.3 (genomic position chr7:95,624,825-
96,135,521). In family 3 a 205 kb deletion on 7q21.3 (gen-
omic position chr7:95,667,046-95,872,044) was detected
(Table 1). Breakpoint spanning sequences are shown in
Additional file 1: Figure S1. In family 4 we detected a
169 kb deletion on 7q21.3 (maximum genomic position
chr7:95,693,341-95,862,369). For family 4, it was not pos-
sible to obtain additional DNA to performer breakpoints
sequencing. All positions are given in hg19.
Deletions of eExons of DYNC1I1 account for
approximately 3% of SHFM/SHFLD cases
In our cohort of 134 unrelated families with SHFM
and SHFLD the following molecular analyses were per-
formed: qPCR for 17p13.3 duplications, qPCR for 10q24
duplications, qPCR for deletions of the eExons 15 and
17 of DYNC1I1 on 7q21.3, and mutational analysis for
TP63. WNT10B mutation analysis was only performed
in seven consanguineous families. Balanced rearrange-
ments were not excluded.
In our cohort, 17p13.3 duplications were identified in
13% (18/134) of the families, 10q24 duplications in 12%
(16/134), TP63 mutations were detected in 4% (6/134),
and deletions of the eExons of DYNC1I1 in 3% (3/134)
(Figure 4). Thus, in 68% of the families with SHFM and
SHFLD no molecular diagnosis was possible.
Conclusions
Congenital malformations represent a major medical
problem with a prevalence of 2-6% in humans [30].
Elucidation of the genetic basis of this heterogeneous
group of disorders has been tremendously successfulTable 1 Microdeletions of various sizes encompassing the
exonic enhancers of DLX5/6 located in exon 15 and 17 of
DYNC1I1 are associated with SHFM1
Family Genomic Location
(hg19)
Size of
Deletion [kb]
Phenotype
1 chr7:95,615,187-95,783,313 167 SHFM
2 chr7:95,624,825-96,135,521 510 SHFM, Hearing
loss
3 chr7: 95,667,046-95,872,044 205 SHFM
4 chr7:95,693,341-95,862,369 169 SHFM
SHFM: Split hand foot malformation.over the last decades by the interpretation of disease re-
lated variations in the 1.5% of protein coding DNA and
the identification of variants that result in the disruption
of specific gene function [31]. However, the growing
number of regulatory mutations mainly located in the non-
coding DNA affecting cis-regulatory elements highlights
the clinical importance of long range gene regulation in
congenital disease [32,33]. Very recently also some exons
of protein coding genes have been identified to act as tissue
specific enhancer elements and were therefore termed
exonic enhancers or “eExons” [34].
In this study, we report on four unrelated families
with overlapping deletions of the cis-regulatory eExons
15 and 17 of DYNC1I1 that act as tissue specific limb
enhancers of DLX5/6 which is located over 900 kb
telomeric on chromosome 7q21.3. In three families with
an autosomal dominant non-syndromic SHFM pheno-
type affecting all four limbs we detected overlapping
microdeletions of 167 kb, 169 kb and 205 kb. The dele-
tions encompass the two limb specific eExons 15 and
17 of DYNC1I1 as well as the last three exons of
the SLC25A13 gene. In family 2 presenting with SHFM
and hearing loss we detected a 510 kb deletion including
the eExons 15 and 17 of DYNC1I1 but also SLC25A13,
C7orf76, two branchial arch enhancers and the human
brain enhancer element hs1642. All four deletions en-
compass the eExons of DYNC1I1. Interestingly, the en-
hancer element eDlx#23 that was shown to drive
reporter expression in otic vesicle, forebrain, branchial
arch and limb bud mesenchyme was also deleted in all
three families, but only family 2 manifested hearing loss
(Figure 3) [21]. Lango Allen et al. reported on a family
with SHFM but without hearing loss carrying a similar
106 kb deletion also including the eExons of DYNC1I1
and the otic vesicle enhancer elements eDlx#23 [35].
These data suggest that the loss of otic vesicle enhancer
eDlx#23 is not pathogenic in these patients. Rather, it is
more likely that hearing loss in family 2 results from the
deletion of the telomeric 264 kb region encompassing two
branchial arch enhancers, the human enhancer element
hs1642, and C7orf76 (Figure 3) [21,28]. The human enhan-
cer element hs1642 shows a tissue specific reporter expres-
sion in the forebrain, the hindbrain (rhombencephalon),
and the neural tube (Figure 3) [28]. This region also
includes the auditory forebrain and might therefore be a
potential candidate for hearing loss [36].
Another large deletion of over 900 kb was described
by Kouwenhoven et al. in an individual that was affected
with SHFM and later also developed hearing loss. In this
study, they showed that p63 binds to an enhancer elem-
ent that is located between SHFM and DLX5/6 [29].
In another recent study Restelli et al. report that the
fibroblast growth factor 8 (FGF8) locus is a downstream
target of DLX5. Furthermore they show that DLX5, p63,
Figure 4 Deletions of eExons of DYNC1I1 account for approximately 3% of SHFM/SHFLD cases: In our cohort of SHFM/SHFLD cases,
17p13.3 duplications were identified in 13% (18/134) of the families, 10q24 duplications in 12% (16/134), TP63 mutations were
detected in 4% (6/134), and deletions of the eExons of DYNC1I1 in 3% (3/134). WNT10B mutation analysis was negative in all seven
consanguineous families investigated. In the majority of families with SHFM and SHFLD (68%) no molecular diagnosis could be made.
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normal patterning and skeletal morphogenesis of the
limb buds [37]. Several other translocations and inver-
sions at the SHFM1 locus have been described that sep-
arate DLX5/6 from their regulators located between
DYNC1I1 and DLX5/6 [21]. Depending on the location
of the breakpoint a genotype-phenotype correlation
seems now feasible. Our results confirm that deletions
of the cis-regulatory eExons 15 and 17 of DYNC1I1
are associated with split-hand/split foot and we reduce
the SHFM1 minimal critical region to 78 kb (Figure 3).
Hearing loss, however, seems to be associated with dele-
tions of a more telomeric 264 kb region encompassing
the brain enhancer element hs1642 (Figure 3). Craniofa-
cial defects seem to result from breakpoints located in
the region closest to DLX5/6 [38].
In order to determine the clinical relevance and preva-
lence of deletions of the eExons of DYNC1I1 we screened
our cohort of SHFM and SHFLD cases. In our cohort of
134 unrelated families with SHFM and SHFLD, deletions
of the eExons of DYNC1I1 on chromosome 7q21.3 account
for approximately 3% of the cases. 17p13.3 duplications
mainly associate with ectrodactyly and tibia hemimelia
[25], while mutations in TP63 are mainly associated with
ectrodactyly without tibial involvement. 10q24 duplications
show the highest phenotypical variability ranging from
single digit shortening to absence of hands and feet.
The introduction of whole exome sequencing into clinical
diagnostics will reveal the role of mutations in DLX5 andWNT10B in SHFM. Our data have a direct impact on diag-
nostics for SHFM since they further highlight the import-
ance of array-CGH as a diagnostic tool for SHFM/SHFLD
and to detect regulatory mutations [39]. Furthermore the
deletions of the eExons of DYNC1I1 are an example of the
emerging role of exonic enhancer elements and their role
in congenital malformations.Additional file
Additional file 1 Figure S1. Confirmation of microdeletions on 7q21.3
by breakpoint spanning PCRs in family 1-3. Table S1: qPCR primers and
sequencing primers for breakpoint detection in family 1-3. (DOC 286 kb)Competing interests
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